
Olmepath CH 40mg/12.5mg Tablet
Marketer
Proqol Healthcare
Salt Composition
Olmesartan Medoxomil (40mg) + Chlorthalidone (12.5mg)
Overview Olmepath CH 40mg/12.5mg Tablet
Each Olmepath CH 40mg/12.5mg tablet combines two active ingredients to manage hypertension through complementary mechanisms. Untreated high blood pressure significantly raises the risk of stroke, heart attack, and kidney complications. This medication can be taken with or without food; dosage is individualized based on your response and overall health. Consistent daily timing is recommended. Continue taking this medicine as directed by your physician. Its diuretic component increases urination, so avoid dosing within four hours of bedtime. Regular use is crucial, even if you feel well, as hypertension is often asymptomatic. Discontinuing treatment increases the risk of cardiovascular events. Common side effects include dizziness, fatigue, nausea, diarrhea, headache, and hypotension. Increased urination is an intended effect of the chlorthalidone component, helping regulate blood pressure, not an adverse reaction. While other side effects are possible, they are usually infrequent. Review the accompanying patient information leaflet and report any persistent or bothersome side effects to your doctor; dose adjustment or alternative medication may be considered. Consult your physician before using this medication if you are pregnant, or have kidney, liver, heart, or diabetic conditions. Alcohol consumption can exacerbate hypotension and potentially worsen side effects.
Primary Ingredients of Olmepath CH 40mg/12.5mg Tablet
No text provided to rephrase.
Uses of Olmepath CH 40mg/12.5mg Tablet
Elevated arterial blood pressure
Major Benefits of Olmepath CH 40mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Olmepath CH 40mg/12.5mg Tablets. Swallow the tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistent daily timing is recommended.
Common Side effects of Olmepath CH 40mg/12.5mg Tablet:
- Nausea
- Taste change
- Diarrhea
- Upset stomach
- Weakness
- Headache
- Increased blood uric acid
- Dizziness
- Increased blood lipid level
- Electrolyte imbalance
- Decreased blood pressure
- Urinary tract infection
- Renal dysfunction
- Sore throat
- Abnormal liver function tests
- Increased potassium level in blood
How to use Olmepath CH 40mg/12.5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Olmepath CH 40mg/12.5mg Tablets can be administered with or without food, although consistent timing is recommended.
How Olmepath CH 40mg/12.5mg Tablet works:
Each Olmepath CH 40mg/12.5mg tablet contains a dual-drug formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Olmepath CH 40mg/12.5mg tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Taking Olmepath CH 40mg/12.5mg tablets during pregnancy poses a confirmed risk to the unborn child. Therefore, it's inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Olmepath CH 40mg/12.5mg tablets while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Olmepath CH 40mg/12.5mg tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Individuals with severe kidney impairment should exercise caution when taking Olmepath CH 40mg/12.5mg tablets. Dosage modification may be necessary; physician consultation is advised. This medication is generally unsuitable for such patients.
LiverCAUTION
Patients with hepatic impairment should use Olmepath CH 40mg/12.5mg tablets cautiously, potentially requiring dosage modification. Severe liver disease contraindicates the use of Olmepath CH 40mg/12.5mg tablets; physician consultation is advised.
What if you forget to take Olmepath CH 40mg/12.5mg Tablet :
Should you forget a dose of Olmepath CH 40mg/12.5mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Olmepath CH 40mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
